Mirum Pharmaceuticals

Mirum Pharmaceuticals

Pharmaceuticals, 950 Tower Ln Ste 1050, Foster City, California, 94404, United States, 201-500 Employees

mirumpharma.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: 65********

Who is MIRUM PHARMACEUTICALS

Mirum Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to transforming the treatment of rare diseases affecting children and adults. Mirum has three approved medications: LI...

Read More

map
  • 950 Tower Ln Ste 1050, Foster City, California, 94404, United States Headquarters: 950 Tower Ln Ste 1050, Foster City, California, 94404, United States
  • 2018 Date Founded: 2018
  • 201-500 Employees: 201-500
  • dollar-icon Revenue: $10 Million to $25 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Pharmaceuticals

SIC SIC Code: 2834 | NAICS Code: 561110 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from MIRUM PHARMACEUTICALS

Mirum Pharmaceuticals Org Chart and Mapping

Employees

Sri Devineni

Associate Director, Medical Safety Operations

Raul Schall

Director of Biostatistics

Anisha Chaudhary

Manager, Clinical Quality Assurance

Susan David

Senior (Medical) Director, Medical Safety

Kaydee Soo

Medical Affairs Project Manager

Andrea Goldstein

Vice President, Medical Affairs

Matthew Harju

Director National Accounts

Adam Zebari

Executive Area Director-East

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Mirum Pharmaceuticals

Answer: Mirum Pharmaceuticals's headquarters are located at 950 Tower Ln Ste 1050, Foster City, California, 94404, United States

Answer: Mirum Pharmaceuticals's phone number is 65********

Answer: Mirum Pharmaceuticals's official website is https://mirumpharma.com

Answer: Mirum Pharmaceuticals's revenue is $10 Million to $25 Million

Answer: Mirum Pharmaceuticals's SIC: 2834

Answer: Mirum Pharmaceuticals's NAICS: 561110

Answer: Mirum Pharmaceuticals has 201-500 employees

Answer: Mirum Pharmaceuticals is in Pharmaceuticals

Answer: Mirum Pharmaceuticals contact info: Phone number: 65******** Website: https://mirumpharma.com

Answer: Mirum Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to transforming the treatment of rare diseases affecting children and adults. Mirum has three approved medications: LIVMARLI (maralixibat) oral solution, Cholbam (cholic acid) capsules, and Chenodal (chenodiol) tablets. LIVMARLI, an IBAT inhibitor, is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome in the U.S. (three months and older), in Europe (two months and older), and in Canada. Mirum has also submitted LIVMARLI for approval in the U.S. in cholestatic pruritus in PFIC patients three months of age and older and in Europe in PFIC for patients two months of age and older. Cholbam is FDA-approved for the treatment of bile acid synthesis disorders due to single enzyme deficiencies and adjunctive treatment of peroxisomal disorders in patients who show signs or symptoms or liver disease. Chenodal has received medical necessity recognition by the FDA to treat patients with cerebrotendinous xanthomatosis (CTX). Mirums late-stage pipeline includes three investigational treatments for debilitating liver diseases. The LIVMARLI development program includes the Phase 2b EMBARK study for biliary atresia. Mirums second investigational IBAT inhibitor is volixibat, which is being evaluated in two potentially registrational studies including the Phase 2b VISTAS study for primary sclerosing cholangitis and Phase 2b VANTAGE study for primary biliary cholangitis. Lastly, Chenodal, is being evaluated in a Phase 3 clinical study, RESTORE, to treat patients with CTX.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access